𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A double-blind, placebo-controlled, enriched population study of tacrine in patients with Alzheimer's disease

✍ Scribed by F. Forette; T. Hoover; S. Gracon; J. de Rotrou; M.P. Hervy; B. Lechevalier; M. Micas; H. Petit; J.M. Orgogozo; O. Guard; D. Saudeau; B. Forette; B. Michel; J. Emile; P. Augustin; A. Wang; J. Vignat; H. Allain; G. Cuny; J. M. Leger; M. Collard; O. Joyeux; R. Khalil

Book ID
115236044
Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
973 KB
Volume
2
Category
Article
ISSN
1351-5101

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A double-blind, placebo controlled, mult
A double-blind, placebo controlled, multicentre study of tacrine for alzheimer's disease
✍ Philip C. Wood; Professor C. Mark Castleden πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 527 KB

The present study was designed to determine whether oral tacrine (tetrahydroaminoacridine, THA) improves the symptoms of patients with mild to moderate Alzheimer's disease. The study was a multicentre, randomized doubleblind, placebo controlled, parallel group study with individual determination of

A 24-week, double-blind, placebo-control
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's diseaseβ€”pilot study
✍ Vee. P. Prasher; Adam Huxley; M. S. Haque πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 163 KB πŸ‘ 1 views

## Abstract ## Background Donepezil Hydrochloride (Aricept) is a selective anticholinesterase inhibitor developed for the treatment of Alzheimer's disease (AD). This study investigated the safety and efficacy of the drug to treat Down syndrome (DS) adults with mild to moderate AD. ## Method This